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EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS
Roberto MARTINEZ
SUMMARY
The epidemiological characteristics of paracoccidioidomycosis were reviewed and updated. The new endemic areas in Brazil were 
discussed in the section regarding the geographic distribution of the mycosis. Subclinical infection with Paracoccidioides brasiliensis 
was discussed on the basis of skin test surveys with antigens of the fungus, seroepidemiological studies, and disease cases outside Latin 
America. Large case series permitted a comparison of the prevalence of the mycosis in different regions, its estimated incidence and 
risk factors for the development of the disease. Aspects modulating the expression of the clinical forms of paracoccidioidomycosis 
are also presented. This review also deals with diseases associated with the mycosis, opportunistic paracoccidioidomycosis, lethality, 
mortality and infection and disease in animals. 
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INTRODUCTION
Paracoccidioidomycosis is an endemic fungal disease acquired 
exclusively in Latin American countries, and that presents a greater 
prevalence in South America. Its etiological agent is the dimorphic 
fungus Paracoccidioides brasiliensis, which causes an infection that 
may progress to systemic granulomatous disease with tegumentary and 
visceral disease. P. lutzii is another species recently identified within the 
genus Paracoccidioides, whose endemic area involves the Midwest and 
North regions of Brazil58. The characteristics of the disease caused by 
P. lutzii are still poorly known and therefore its epidemiology will not 
be considered in the present review.
Natural infection with P. brasiliensis occurs in men and animals and 
is acquired by the respiratory route after inhalation of fungal conidia 
suspended in air. Epidemiological surveys have permitted to estimate that 
many people have been infected with P. brasiliensis without developing 
the mycosis. This condition is known as paracoccidioidomycosis-
infection, in which the presence of the latent fungus in residual lung 
lesions and mediastinal lymph nodes is possible. Transmission of the 
disease through the skin or the mucosa is unlikely due to the low number 
of fungal propagules inoculated subcutaneously in small traumas. 
A case of accidental percutaneous inoculation in the laboratory only 
caused a local granulomatous reaction18. There is no evidence of human 
transmission of paracoccidioidomycosis.
Paracoccidioidomycosis disease manifests as two main clinical forms 
that are epidemiologically distinct. 
The acute/subacute form commonly affects children and young 
adults who tend to show more disseminated lesions. This form of the 
mycosis is assumed to appear a few weeks or months after infection 
with P. brasiliensis and therefore such cases, especially those involving 
children, are indicators of endemic areas of paracoccidioidomycosis77. 
The chronic form of the disease is more common among adult men 
who present lesions usually involving the oral mucosa, the airways 
and the lungs. This form of the disease manifests months to years 
after P. brasiliensis infection and has been associated with specific 
risk factors.
Paracoccidioidomycosis has a great medical and social impact in 
the areas of higher endemicity, not only because of the considerable 
number of cases, but also because of the chronicity of the disease, the 
long duration of treatment and the frequent sequelae that cause inability to 
work and poor quality of life. Among the causes of chronic granulomatous 
infectious diseases in Brazil, paracoccidioidomycosis is less frequent 
than tuberculosis, but is more common than histoplasmosis. Conversely, 
opportunistic histoplasmosis occurring in AIDS and other types of 
immunosuppression is more frequent than paracoccidioidomycosis. 
The approach to the epidemiology of P. brasiliensis disease meets 
some difficulties due to the fact that case notification is not obligatory and 
to the difficulty in recognizing recently acquired infection, the absence of 
epidemic outbreaks, and also the deficient laboratory diagnostic capacity 
in some endemic areas. The epidemiology of paracoccidioidomycosis 
should be complemented with the ecology of the mycosis, which is 
reviewed in the same issue of this journal. 
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Geographic distribution
Delimitation of the endemic area: Autochthonous cases of 
paracoccidioidomycosis are limited to the American continent, 
approximately between 23°N and 35° S, i.e., from Mexico to Argentina77. 
The distribution of cases of paracoccidioidomycosis and the rates of 
infection with P. brasiliensis in population samples are heterogeneous in 
different countries and in different regions of each country and reveal the 
areas with higher endemicity. About 80% of the cases reported occurred in 
Brazil, and most of the remaining ones occurred in Venezuela, Colombia 
and Argentina. Autochthonous human paracoccidioidomycosis has not 
been reported in some countries such as Chile, Guyana, Surinam, French 
Guyana, Belize and Nicaragua. A large endemic area exists in Brazil, 
comprising the Southeast (States of Sao Paulo, Rio de Janeiro, Espirito 
Santo and Minas Gerais), Midwest (mainly the States of Goias and Mato 
Grosso do Sul) and South (from Parana to the North of Rio Grande do 
Sul). A second endemic area is located along the Eastern border of the 
Amazon region, including the States of Para, Maranhao and Tocantins28. 
A third area that became relevant at the beginning of the 21st century 
comprises the Western Amazon region and the State of Rondonia in 
particular96. In contrast, a large part of the Brazilian Northeast has low 
endemicity of paracoccidioidomycosis and no autochthonous cases 
appear to exist in this semi-arid region.
The endemic area of Mexico is located in the South between the 
Gulf of Mexico and the Pacific Coast51. In this region, as well as in all 
of Central America, the endemicity of the mycosis is low. The endemic 
area of Venezuela is mainly located in the North and in the State of 
Bolivar60, while in Colombia paracoccidioidomycosis is more prevalent 
in the Andean region89. Endemicity is also recognized in the Rio Cuenca 
Valley in Ecuador49, in the region of the Peruvian Amazon forest13, 
in the Northeast and Northwest of Argentina94, in the Eastern half of 
Paraguay81, and in most of the Bolivian territory with tropical climate95. 
The endemicity of paracoccidioidomycosis is low in other regions of 
South America such as Uruguay23, and the epidemiological situation is 
unknown in extensive territories of various countries.
Social and environmental changes with an epidemiological impact: 
The number of cases of paracoccidioidomycosis is small among Brazilian 
indigenous populations whose subsistence is based on hunting and 
fishing38 and also in a case series of the Amazon region between 1973 
and 198388, where there was a higher prevalence of lobomycosis. The 
first known change in the epidemiology of the mycosis possibly occurred 
in the Brazilian Southeast in the first half of the 20th century, when 
agricultural activity has strongly expanded, particularly regarding coffee 
culture. Japanese and European immigrants were recruited to work on 
coffee plantations or in other activities linked to the soil. Many of these 
immigrants acquired paracoccidioidomycosis, so that 38% of the 750 
cases diagnosed in the city of Sao Paulo up to 1945 involved immigrants 
from Japan, Portugal, Spain and Italy2. The agricultural expansion that 
occurred in the states of Maranhao and Para during the second half 
of the 20th century was probably causally related to the endemic area 
located in the Eastern border of the Amazon region28. Since 1997 there 
is a great elevation in the number of paracoccidioidomycosis cases in 
Rondonia, particularly in the Southeast region of this state located in 
Western Amazon. This new hyperendemic area developed recently, a 
fact attributed to deforestation and to the wide expansion of agriculture 
and cattle breeding, in addition to the arrival of many immigrants from 
various states96. In the same region, cases of the mycosis occurred 
among Indians of the Surui tribe, who changed their subsistence habits 
and started to work on coffee culture. Skin tests demonstrated that P. 
brasiliensis infection was more common in this tribe than in neighboring 
tribes not involved with agricultural activity22.
Environmental and climate changes may cause alteration of the 
epidemiology of the mycosis. The construction of the Yacyreta dam 
in the Northeast of Argentina altered the valley of the Parana River 
and had an impact on the rates of paracoccidioidomycosis-infection 
among the inhabitants of the region, where cases of the mycosis were 
previously rare56. A similar modification may have occurred in the 
South of Brazil in the micro-region of the Itaipu dam, where 102 cases 
of paracoccidioidomycosis were recorded during a period of 18 months 
from 2008 to 200952.
Climate changes, particularly the increased air and soil humidity in 
previous years, were associated with an increased incidence of cases of the 
acute/subacute form of the mycosis6. In contrast, a progressive reduction 
of number of cases of acute/subacute form of paracoccidioidomycosis 
was observed in the Mato Grosso do Sul State, which may have been a 
consequence of the public control policy and reduction of child labor33. 
Other epidemiological changes can be expected due to the growing 
urbanization of the population and the changes in agricultural practices, 
such as mechanization of farm work and the replacement of coffee with 
sugar cane plantations in the Brazilian Southeast.
Paracoccidioidomycosis in non-endemic countries: At least 60 cases 
of paracoccidioidomycosis have been reported and diagnosed in countries 
outside Latin America. The cases were observed in the United States 
of America, Canada, Spain and other European countries, the Middle 
East, Japan and Africa. The first 42 cases were reviewed in 19851 and 
other 21 cases diagnosed in Spain since 1962 were reviewed in 201212. 
In Japan, imported paracoccidioidomycosis was identified in at least 17 
patients and a tendency to an increase in the annual number of cases was 
observed45. The most recent cases were observed in Germany86, England97, 
Spain67, France47, the Netherlands92 and Japan70. Each patient had been 
previously visiting one or more South American countries, including 
Brazil, Venezuela, Bolivia, Ecuador, Argentina and Paraguay. 
All 60 cases were considered to be imported paracoccidioidomycosis 
since the patients had reported visiting or working in South or Central 
American countries. Some of them had left the endemic area already 
presenting clinical manifestations of the mycosis, but most of them had 
shown lesions after at least five years of permanence in non-endemic 
countries. These cases are indicators of endemic sites of the mycosis. 
Paracoccidioidomycosis-infection
Surveys with skin reactions: The skin test with the intradermal 
application of P. brasiliensis antigens is used to assess delayed 
hypersensitivity and is the method most frequently used to detect 
asymptomatic infection with the fungus. Many epidemiological surveys 
for the assessment of paracoccidioidomycosis-infection have been 
conducted on samples of the general population or on children and other 
selected groups in Latin American countries. Studies on large numbers 
of individuals were started in 1951 and the results of many of them were 
included in two reviews published in 198873 and 199835. Table 1 shows a 
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similar mean reactivity of 25 to 35% observed in four of five Brazilian 
regions. The lowest rate was observed in the North region (16%). The 
mean percentage for the Northeast (30.6%) is relatively high and is 
in contrast to the small number of cases of the mycosis in most of the 
States in this region. Despite the wide variability in the percentage of 
reactivity detected in each study, even in areas close to one another, the 
results suggest that infection with P. brasiliensis can be acquired in a 
large extension of the Brazilian territory. Studies conducted in other 
South American countries have shown higher population reactivity in 
Venezuela, Colombia and Ecuador. A single study carried out in Chile 
did not detect individuals reacting to P. brasiliensis (Table 1).
In general, studies with the skin test show that men and women are 
equally infected with P. brasiliensis and that infection already occurs 
during the first and second decades of life44. The rate of reactivity 
increases with age and reaches maximum percentages between 30 and 60 
years57. The percentage of reactivity is higher in the skin test applied to 
rural populations, farmers, cattle raisers and other professionals working 
in the rural area21,27,57.
There are limitations to the interpretation of skin test results and to the 
comparison of studies. Different P. brasiliensis antigens lead to different 
rates of reactivity44. There is also evidence of cross-reactivity when the 
skin test is applied to people infected with Histoplasma capsulatum, 
although infection with both fungi should be considered35. 
Many epidemiological surveys using the skin test have been 
performed during the second half of the 20th century. This fact causes 
difficulties in determining the prevalence of paracoccidioidomycosis-
infection due to the social and environmental changes that occurred 
later. Four surveys were conducted over the last 15 years and, except for 
one of them which investigated only children, the others showed rates 
of reactivity to the gp43 antigen of 43% to 47% among people living in 
the Southeast and South regions of Brazil39,53,57. Recent studies conducted 
in Argentina and Venezuela have also revealed 4% to 20% rates of 
population reactivity to P. brasiliensis20,93. The surveys conducted over the 
last decades have permitted the assumption that asymptomatic infection 
with P. brasiliensis continues to occur in rural areas and that millions of 
people with paracoccidioidomycosis-infection exist in South America.
Seroepidemiology: The search for anti-P. brasiliensis antibodies 
in population samples has also demonstrated the presence of 
paracoccidioidomycosis-infection. Antibodies against the exoantigen 
of this fungus were detected in 27% of 680 blood donors in four 
municipalities in Northeastern Parana, Brazil54. In an indigenous area in 
the North of the Minas Gerais State, 5% and 3.9% of the 180 inhabitants 
had a positive serological test to P. brasiliensis and H. capsulatum, 
respectively. Higher antibody titers were detected in young adults, 
suggesting that the infection occurs early in life63. Among those with 
paracoccidioidomycosis-infection, anti-P. brasiliensis antibody titers 
are barely increased and may be detected only over a short period of 
time. For this reason, serological tests are less sensitive than skin tests 
for revealing paracoccidioidomycosis-infection in population samples. 
Cases of paracoccidioidomycosis-infection: Cases with a 
clinical diagnosis of P. brasiliensis infection made during the period 
Table 1
Paracoccidioides brasiliensis intradermal test - paracoccidioidomycosis infection populational rate according to geographic area 
Country/Geographic area Study 
n0 (time) Antigen type
Number 
of persons
Reactors 
% (range) References
Brazil-North (AP-AM-RO-PA) 8 (1975-1994) pol 3,772 16.0 (6.4-27.0) 22-35
Brazil-Northeast (MA-PI-CE-RN-PB-AL-BA) 11 (1974-1990) pol 4,637 30.6 (3.0-57.4) 35-73
Brazil-Center West (GO-MT-MS) 4 (1968-2013) pol-gp43 2,509 26.9 (4.6-45.8) 35-44-57-73
Brazil Southeast (MG-RJ-SP) 25 (1951-2014) pol-gp43 15,038 25.1 (2.0-68.7) 35-53-73-85
Brazil-South (PR-SC-RS) 5 (1966-2005) pol-gp43
MF-YF
1,041 34.4 (3.3-82.0) 35-39-73
Venezuela 5 (1971-2009) pol-MF 2,959 22.8 (6.1-52.0) 19-20-21-73
Colombia 3 (1968-1993) YF-MF 5,651 9.7 (8.9-45.0) 15-73
Argentina 6 (1952-1999) pol-MF 1,605 5.4 (0.9-11.4) 40-55-56-93-94
Uruguay 2 (1953-1957) YF 591 3.2 (2.0-15.4) 40
Ecuador 1 (1986) pol 998 41.3 49
Chile 1 (1957) YF 137 0.0 73
Guyana 1 (1987) pol 49 31.0 41
Panama 2 (1989) YS 351 16.5 (9.0-26.2) 26-27
% reactivity: geometric mean of different studies in the same region; antigen type: pol-yeast polysaccharide; gp43 - purified glycoprotein of 43,000 kDa; MF - mycelial 
filtrate; YF - yeast filtrate; YS - yeast sonicated. Data of studies before 1998 were obtained from the reviews of FAVA and FAVA (reference 35), PEREIRA (reference 
73), and GREER and RESTREPO (reference 40). AP - Amapa; AM - Amazonas; RO - Rondonia; PA - Para; MA - Maranhao; PI - Piaui; CE - Ceara; RN - Rio Grande 
do Norte; PB - Paraiba; AL - Alagoas; BA - Bahia; GO - Goias; MT - Mato Grosso; MS - Mato Grosso do Sul; MG - Minas Gerais; RJ - Rio de Janeiro; SP - São Paulo; 
RS - Rio Grande do Sul; PR - Parana; SC - Santa Catarina.
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when infection occurred are rare. The infection is considered to be 
asymptomatic or to manifest with discrete and short-lasting respiratory 
symptoms. Focal pulmonary lesions and hilar lymphadenomegaly have 
been observed in patients in whom the primary complex of P. brasiliensis 
infection was identified before the disease. The clinical and radiological 
expression may be different from that observed in typical cases of the 
disease, impairing the recognition of infection with this fungus62. On 
the other hand, when paracoccidioidomycosis disease affects patients 
with AIDS and with other types of immunosuppression, this suggests 
reactivation of a previously acquired subclinical infection66. Certainly, 
individuals who manifest paracoccidioidomycosis disease after a long 
time living outside Latin America are cases of subclinical disease until 
the onset of the mycosis. Paracoccidioidomycosis-infection has been 
also identified by recognizing P. brasiliensis in residual lesions detected 
at autopsy in individuals whose death was caused by other diseases4. 
There are also reports of rare cases of mildly symptomatic individuals 
with a pulmonary paracoccidioidoma, a nodular lesion caused by the 
persistence of the inflammatory reaction and fibrosis around the fungus 
acquired during the primary infection31.
Paracoccidioidomycosis-disease
Prevalence: More than 15,000 cases of paracoccidioidomycosis 
have been reported between 1930 and 2012, a number that only partially 
reflects the prevalence of the disease in Latin America. Table 2 contains 
data obtained from large case series and shows a high annual mean 
number of cases reported in the known endemic areas of the Brazilian 
Southeast, South, Midwest and, currently, also in the Western Amazon 
region of Brazil. An expressive, although smaller number of cases of 
the mycosis are found in the area of the States of Para, Maranhao, Piaui 
and Tocantins. Most of the States in the Brazilian Northeast have few 
autochthonous cases of the mycosis that were not included in Table 
2. Colombia, Venezuela and Argentina have a smaller annual number 
of cases than Brazil, with the possibility of an overestimated rate for 
Argentina which was represented by a national study based on a survey 
performed in clinical laboratories25, and an underestimated rate for 
the other two countries. The prevalence of paracoccidioidomycosis is 
apparently low in other Latin American countries.
Incidence: Table 3 shows that the incidence of paracoccidioidomycosis 
in stabilized endemic areas of the Brazilian Southeast and South regions 
was estimated at 0.71 to 2.70/100,000 inhabitants/year. In the micro-
region of Ribeirao Preto, Sao Paulo State, the annual incidence ranged 
from 1.5 to 3.7 new cases/100,000 inhabitants/year9. Comparatively, the 
mean incidence in the Rondonia State (9.40/100,000 inhabitants/year) is 
very high, especially in some municipalities that reached an incidence 
almost four times higher than the mean for the State96. These findings 
characterize this part of the Western Amazon region as a hyper endemic 
area, although already showing a tendency to a progressive reduction 
of incidence. South American countries have a lower incidence of 
paracoccidioidomycosis than Brazil. An extensive study conducted in 
Colombia has revealed a wide heterogeneity among the municipalities 
investigated, some of which had an incidence similar to those of the 
Brazilian Southeast16. Various studies support the estimate that the 
incidence of paracoccidioidomycosis in stabilized areas of Brazil ranges 
from one to four new cases/100,000 inhabitants/year. The incidence of 
the mycosis can temporarily reach higher rates in areas with great socio-
environmental changes.
Table 2
Paracoccidioidomycosis prevalence evaluated by some representative case series according to geographic area 
Country/Region/State Cases n0 Period Annual number of 
cases*
References
Brazil
Eastern Amazonia (MA-PA-TO) 458 1980-2007 17.0 28-36
Western Amazonia (RO-AM-AC) 2,163 1973-2012 146.1 88-96
Center West (GO-MS-DF) 902 1968-2009 49.2 3-17-33
Southeast (MG-ES-RJ-SP) 6,784 1930-2012 207.8 5-6-8-11-46-69-91
South (PR-RS) 2,169 1966-2009 140.6 42-50-52-80-87
Mexico 93 1972-2002 3.1 51
Venezuela 674 1984-2010 25.9 60
Colombia 940 1970-1999 32.4 16
Ecuador 310 1950-1983 9.4 49
Peru 111 1937-1971 3.3 13
Argentina 110 2004 110.0 25
Paraguay 50 1960-1969 5.0 81
Uruguay 48 1933-1975 1.1 23
(*) The mean number of cases per year reported in different studies in the same region was summed. The studies that can duplicate data were excluded. MA - Maranhao 
State; PA - Para; TO - Tocantins; RO - Rondonia; AM - Amazonas; AC - Acre; GO - Goias; MS - Mato Grosso do Sul; DF - Distrito Federal; MG - Minas Gerais; ES 
- Espirito Santo; RJ - Rio de Janeiro; SP - São Paulo; PR - Parana; RS - Rio Grande do Sul State. 
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It is also possible to estimate the incidence based on the cause 
of deaths found in the medical records. The mortality due to 
paracoccidioidomycosis ranged from 0.9 to 1.0/1,000,000 inhabitants/
year in Brazil, corresponding to a mean number of 168 deaths per 
year during the period from 1996 to 200675. Considering 5% as the 
representative value for lethality of the mycosis, we may estimate 
its mean incidence at about 2.0/100,000 inhabitants/year, i.e., 3,360 
new cases per year in Brazil64. Using the same method, the estimated 
incidence of the mycosis exceeds 3/1,000,000 inhabitants/year in some 
Brazilian States.
Demography and other factors associated with the disease
In addition to the type of immunological response in P. brasiliensis 
infection, genetic constitution, demographic characteristics and life 
style are factors involved in the progression to paracoccidioidomycosis.
Age: Cases ranging in age from two to 102 years have been 
reported50,74. The prevalence is higher between 30 and 60 years of age and 
less frequent during the first decade of life and after 70 years of age11,91. 
The higher prevalence during adulthood is probably related to a greater 
exposure to the fungus during professional activities. Age is strongly 
associated with the clinical expression of paracoccidioidomycosis. The 
acute/subacute form is more prevalent during the first three decades of 
life and is the only form affecting children up to 15 years of age. The 
chronic form is the usual clinical presentation after 30 years of age8.
Gender: Children of both genders are equally affected by the 
mycosis74. After puberty, paracoccidioidomycosis predominates among 
men, but the male: female ratio varies according to geographic region, 
from 3:1 to 10:1 in the Brazilian Southeast and Midwest3,11, but may reach 
higher proportions, close to 100:1 in series of cases from the Brazilian 
South region and other South American countries40,50. Although infected 
with P. brasiliensis at rates similar to those for men, women are protected 
by the inhibitory action of beta-estradiol on the fungus, which inhibits the 
formation of yeast cells from the inhaled conidia and also modulates the 
cell immune response83. Another reason for the lower prevalence of the 
mycosis among women is their less intense involvement in agricultural 
activities, which may also be the reason for the variability in the male: 
female proportion in different endemic areas. Paradoxically, adult 
women have a higher risk to present the more disseminated lesions of 
the acute/subacute form8. The reasons for this fact are unknown, but may 
be attributed in part to pregnancy which, in some cases, is associated 
with paracoccidioidomycosis86. Pregnancy temporarily reduces the 
immunological response and is a predisposing factor to fungal diseases.
Ethnicity: Large case series have not shown racial predisposition to 
the development of paracoccidioidomycosis, since patient distribution 
according to skin color has been similar to that of the general population. 
However, in a miscigenated population it was observed that blacks and 
mulattoes tended to have an increased prevalence of the acute/subacute 
form, whereas white patients showed a predominance of the chronic 
form of the mycosis8. This difference may be possibly related to genetic 
variability and the type of immunological response. 
Living and working in the rural area: More than 90% of the 
paracoccidioidomycosis patients from the interior of Brazil had a 
prolonged contact with the rural area either because of their occupation, 
or because they lived in this environment. About 50% to 80% reported 
current occupation in agriculture and cattle raising, particularly direct 
soil management on farms dedicated to vegetable culture28,72. Coffee 
and tobacco cultures have been associated with paracoccidioidomycosis 
and apparently involve a higher risk of inhaling P. brasiliensis conidia 
present in soil16,85,89. Five to ten percent of the patients are brick layers 
and other civil construction workers and about 5% are professional 
drivers of agricultural machines or vehicles on highways9,59. Although 
the mycosis is strongly related to the rural environment, cases of 
paracoccidioidomycosis acquired in the suburban area have also been 
reported.
Genetic background: The different racial composition of endemic 
countries may eventually modulate the development and expression of 
paracoccidioidomycosis, e.g., the proportion of cases of the clinical 
forms of the disease. Some studies on the major histocompatibility 
complex have suggested that the genetic background may influence 
the development of the disease. The leukocyte antigens HLA-A9 and 
HLA-B13, as well as the HLA-B4 haplotype were more common 
among patients from Colombia and Brazil48,78, respectively, than in the 
corresponding general population. The C4B*-00 antigen of the class III 
major histocompatibility complex has been associated with the chronic 
form of paracoccidioidomycosis29. 
Living conditions: Life style and certain circumstantial factors have 
an impact on the development of P. brasiliensis disease. Smoking is 
strongly associated with the chronic form of paracoccidioidomycosis, it 
is observed in more than 90% of the patients and the risk for the mycosis 
is 14 times higher in smokers than in nonsmokers32,80. Alcohol drinking, 
with a mean consumption of distilled beverages exceeding 50 g or 60 mL 
per day, has also been associated with the chronic form of the disease, 
and the cure of the patient under treatment is impaired when the mean 
consumption exceeds 100 mL/day32,61. The role of malnutrition as a 
Table 3
Incidence (new cases/100,000 inhabitants/year) of paracoccidioidomycosis 
according to geographic area 
Country/City/Region Period Incidence (mean) Reference
Brazil Sao Paulo (SP) 1967 0.96 46
Ribeirao Preto (SP) 1980-1999 2.70 9
Rio de Janeiro (RJ) 1960 0.71 40
Santa Maria (RS) 1958-1987 0.90 50
Rondonia (RO) 1997-2012 9.40 96
Argentina Chaco 1972 0.80 40
Colombia Antioquia 1973 0.35 40
Six municipalities* 1970-1999 0.81-3.08 16
Paraguay 1960-1969 0.52 81
(*) 6/216 municipalities with major incidence. Some data were obtained from 
the GREER and RESTREPO review (reference 40). SP - Sao Paulo; RJ - Rio de 
Janeiro; RS - Rio Grande do Sul; RO- Rondonia. 
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predisposing factor is uncertain, since in general it is a consequence of 
the disease itself. Nutritional changes have a greater impact on children74 
and may contribute to the development of the mycosis among alcohol 
drinkers.
Associated diseases 
Certain chronic infectious diseases and neoplasias have been 
associated with paracoccidioidomycosis and are diagnosed simultaneously 
to, before or after the mycosis. Pulmonary tuberculosis is the most 
common associated disease and its occurrence is also presumed to be 
related to smoking and to alcohol drinking, observed in many patients. 
This disease affects 1.7% to 15% and, exceptionally, more than 20% of 
the patients with paracoccidioidomycosis52,72,96. When the diseases are 
concomitant there may be a delay in the diagnosis of the mycosis76. Other 
infectious and parasite diseases such as leishmaniasis, leprosy, Chagas 
disease and strongyloidiasis affect a small portion of patients and are 
probably a consequence of common predisposing conditions9.
Neoplasias occur in 0.16% to 14.1% of patients with 
paracoccidioidomycosis and in some of these cases the diagnosis of the 
two medical conditions is made simultaneously, as reported in a review 
by SHIKANAI YASUDA et al.84. There is a predominance of carcinomas 
commonly located in the respiratory and digestive tracts, but the mycosis 
has also been observed in association with lymphomas and leukemia. 
Carcinomas are more frequent among patients with the chronic form of 
paracoccidioidomycosis and in many cases they are located in the same 
anatomical site of the fungal lesion or close to it. In addition to the fact that 
the patients have risk factors for the development of both the mycosis and 
of the neoplasia, an increased risk for neoplasia is presumed to exist due 
to a modified immunological response and/or the chronic inflammation 
caused by the persistence of P. brasiliensis in the tissues80. However, 
there is no scientific evidence showing that paracoccidioidomycosis is 
an independent risk factor for the development of neoplasias.
Opportunistic paracoccidioidomycosis: P. brasiliensis may be 
an occasional opportunistic agent in patients with impaired cellular 
immune response, usually as a consequence of reactivation of the 
fungus in residual lesions of a previous infection. Several cases of 
paracoccidioidomycosis affecting patients with hematological or solid 
organ neoplasias have been reported, and the mycosis was diagnosed 
simultaneously to or after the occurrence of cancer in 40% to 60% of 
them80,84. Opportunistic paracoccidioidomycosis has also been reported in 
patients submitted to renal transplantation98, in isolated cases of CD40L 
(Ligand) deficiency14 and in patients with genetic polymorphisms in the 
interleukin 12 receptor65.
P. brasiliensis/HIV coinfection has been reported in South American 
countries, and in Brazil in particular. In endemic areas, 1.4% to 1.5% 
of AIDS patients present opportunistic paracoccidioidomycosis, 
usually more disseminated, with a higher early mortality rate and lower 
percentage of cure after antifungal treatment66,71. HIV infection was 
detected in approximately 5% of the patients with the mycosis66, and 
1.4% of the deaths caused by fungal disease in AIDS patients of Brazil 
have been attributed to paracoccidioidomycosis75. The epidemiological 
characteristics of the mycosis in patients with AIDS differ from those 
known for the endemic paracoccidioidomycosis, since the patients are 
more urbanized and are younger, with a greater proportion of women.
Lethality and mortality
Lethality: Before the introduction of sulfonamides in 1940, all 
patients with paracoccidioidomycosis died due to complications of 
progressive disease. Even with the introduction of antifungal agents, 
lethality continued to be high, about 16.2% to 27.0% at the end of 
treatment, according to a review of the data obtained in some Brazilian 
studies30. Death was the outcome for 12.3% of cases in a series of patients 
with the chronic form of the mycosis5. In Argentina, evaluation at the end 
of treatment showed the occurrence of death in 2.2% of 90 patients68. 
Two more recent series involving a large number of cases showed 7.6% 
and 6.1% lethality in different endemic areas of Brazil72,96. A lethality 
rate of 9.3% was observed among children attending a university hospital 
in the Southeast of Brazil74. The deaths occurring before or during the 
early phase of treatment are related to delayed diagnosis, multiple 
lesions due to dissemination of P brasiliensis and complications of 
paracoccidioidomycosis, such as respiratory failure, adrenal insufficiency, 
tissue necrosis causing perforation of the viscera and hemorrhage, 
lymphocyte depletion, and advanced age10. The deaths occurring over 
the years following treatment of the mycosis are usually a consequence 
of sequelae, particularly respiratory dysfunction. 
Mortality: In Brazil, 3,181 deaths due to paracoccidioidomycosis 
have been recorded from 1980 to 1985, corresponding to a mean annual 
mortality rate of 1.45 per million inhabitants24. Of the deaths due to fungal 
infections, 51% were attributed to paracoccidioidomycosis75. Deaths 
occurred in all Brazilian States, although mortality rates were higher in 
endemic areas in the South, Midwest and Western Amazon regions. The 
distributions according to sex, age and professional activity were similar 
to those of paracoccidioidomycosis-disease. The deaths mainly occurred 
during the winter months, apparently as a consequence of complications 
and sequelae in the respiratory tract82. In Brazil, between 1996 and 2006, 
paracoccidioidomycosis was recorded as an associated cause of death in 
0.67 per 1,000 deaths of patients with AIDS75.
Paracoccidioidomycosis in animals
The disease and particularly P. brasiliensis infection have been 
demonstrated in different species of domestic and wild animals. An 
armadillo species (Dasypus novemcinctus) is more associated with 
the eco-epidemiology of paracoccidioidomycosis, being frequently 
infected or showing histopathological changes suggestive of disease 
caused by P. brasiliensis. In addition to having a geographic distribution 
approximately equal to that of the mycosis, armadillos dig and produce 
aerosols with soil particles and are probably infected by inhaling fungal 
conidia in suspension in the air, as is the case in humans77. Disseminated 
paracoccidioidomycosis was also detected in a two-toed sloth that died 
after being captured in Guyana, a fact that demonstrates the endemicity of 
this region90. Structures similar to those of P. brasiliensis were observed 
in the liver of a squirrel monkey captured in Bolivia43. Regarding 
domestic animals, paracoccidioidomycosis was confirmed by isolation 
of the fungus and/or histopathological examination in two dogs from the 
Brazilian Southeast which showed lymphadenomegaly34,79.
Serological surveys or skin tests with P. brasiliensis antigens have 
revealed the existence of paracoccidioidomycosis-infection in cats, dogs, 
chickens, pigs, cattle, horses, sheep, goats, rabbits and in monkeys and 
in other free or captive wild animals. Anti-P. brasiliensis antibodies 
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have been detected in 2% to 90% of wild or urban animals evaluated 
and the percentage of infected urban animals was related to the degree 
of exposure to the environment. Dogs living in the rural area have a 
higher rate of infection than dogs living in the urban area37. Freely raised 
rabbits have higher rates of infection than caged animals and 83% of 
the rabbits exposed to natural infection develop antibodies against P. 
brasiliensis7. However, no lesions caused by P. brasiliensis have been 
detected in anatomopathological exams of animals reactive to antigens 
of the fungus in serological or skin tests37. This suggests that, except 
for armadillos, there is low risk of paracoccidioidomycosis-infection to 
progress to fungal dissemination and disease in animals.
CONCLUSION
The epidemiology of paracoccidioidomycosis had already been 
delineated since the middle of the 20th century40 but new data have shown 
that it is not stable and may undergo changes along time. More than 
a simple contact with the rural area and the forest, the type of human 
interaction with the environment has a great impact on the acquisition 
of infection with P. brasiliensis. This involves deforestation, extensive 
and continued agriculture and human migration to scarcely inhabited 
and unexplored regions, in addition to the environmental impact of large 
constructions. New endemic regions have been revealed in Brazil since 
the second half of the 20th century. The urbanization of the population 
under inappropriate conditions has favored infection and disease at 
the periphery of cities. On the other hand, the prevalence of the acute/
subacute form of the mycosis tends to be reduced in the Midwest region 
and a similar tendency was observed for the paracoccidioidomycosis 
mortality in Brazil. The clinical expression of paracoccidioidomycosis 
is associated with individual demographic characteristics and perhaps 
with the racial composition of the population of each endemic area. 
Paracoccidioidomycosis has morbidity and mortality rates comparable to 
those of other chronic endemic parasite infections and is considered to be 
an occupational disease and, due to frequent sequelae, its medical-social 
impact may extend for years after antifungal treatment.
RESUMO
Epidemiologia da paracoccidioidomicose
As características epidemiológicas da paracoccidioidomicose 
foram revistas e atualizadas. Novas áreas endêmicas brasileiras foram 
discutidas na seção de distribuição geográfica da micose. A infecção 
subclínica por Paracoccidioides brasiliensis foi discutida com base em 
pesquisas realizadas com testes cutâneos com antígenos do fungo, estudos 
soroepidemiológicos e em casos de doença, fora da América Latina. 
Grandes séries de casos permitiram a comparação da prevalência da 
micose em diferentes regiões, sua incidência estimada e fatores de risco 
para o desenvolvimento da doença. Aspectos modulando a expressão 
de formas subclínicas da paracoccidioidomicose foram igualmente 
apresentados. Esta revisão também trata de doenças associadas à micose, 
paracoccidioidomicose oportunista, letalidade, mortalidade e infecção 
e doença em animais. 
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